Back
ESC Professional Premium Access

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Session: Cardiac amyloidosis: my heart is filled with so much…
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr S. Muller (Utrecht, NL)
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Mr Steven Anton Muller

Utrecht (Netherlands (The))
1 presentation
0 follower

4 more presentations in this session

Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records

Speaker: Doctor L. Anderson (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Usefulness of scintigraphy with [99mTc]Tc-DPD for the detection of transthyretin cardiac amyloidosis. Reference centre experience in an endemic area.

Speaker: Doctor N. Orta (Palma de Mallorca, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiac magnetic resonance T1 imaging for the diagnosis of cardiac amyloidosis among patients with symptomatic heart failure

Speaker: Doctor R. Gessner (Leipzig, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

Speaker: Doctor M. Zampieri (Florence, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiac amyloidosis: my heart is filled with so much…

Speakers: Mr S. Muller, Doctor L. Anderson, Doctor N. Orta, Doctor R. Gessner, Doctor M. Zampieri
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources